HIGHLIGHTS
- who: from the Next-generation antigen-presenting cell immune therapeutics for gliomas Catalina Lee-Chang1, and Maciej SLesniak1, Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA. Malnati Brain Tumor Institute, Chicago, Illinois, USA. have published the research work: The Journal of Clinical Investigation, in the Journal: (JOURNAL)
- what: The aim of APC vaccination is to harness T_cell antitumor immunity by the presentation of TAAs.
- how: Pioneered by Liau et_al the first DC vaccines were tested in GBM patients using acid-eluted tumor Ags . This study (NCT00639639) was performed . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.